Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for PK and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for PK and 80,000+ other tickers.
See exactly how PK's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for PK and 80,000+ other tickers.
Park Hotels & Resorts Inc. operates as the second-largest publicly traded real estate investment trust (REIT) focused on the lodging sector. It manages a diversified collection of 60 premium-branded hotels and resorts, which are market leaders and possess considerable underlying real estate value. These properties include over 33,000 guest rooms, predominantly situated in prime urban centers and popular resort destinations.
TYSONS, Va.--(BUSINESS WIRE)---- $PK--Park Hotels & Resorts Inc. (NYSE: PK) (“Park” or the “Company”) today announced the publication of its ninth annual Corporate Responsibility (“CR”) Report. The CR Report details Park's approach to responsible risk management, environmental stewardship, social impact and governance and highlights the Company's corporate responsibility performance, initiatives and achievements in 2025. “We are pleased to share our annual Corporate Responsibility Report with our s.
Park Hotels and Resorts Inc. (NYSE: PK - Get Free Report) hit a new 52-week high during mid-day trading on Friday. The stock traded as high as $16.33 and last traded at $16.2940, with a volume of 646,195 shares. The stock had previously closed at $15.72. Analysts Set New Price Targets Several equities research analysts recently
[url="]PureTech Health plc[/url] (LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and tran
[url="]Seaport Therapeutics, Inc.[/url] (Nasdaq: SPTX) (âSeaportâ or the âCompanyâ), a clinical-stage therapeutics company developing novel neuropsychia
These stocks are up significantly in 2026, yet still look undervalued today.